Procyon Advisors’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,229
Closed -$557K 520
2024
Q1
$557K Buy
4,229
+183
+5% +$22.5K 0.04% 309
2023
Q4
$585K Sell
4,046
-2,556
-39% -$351K 0.05% 287
2023
Q3
$1.12M Buy
6,602
+3,399
+106% +$677K 0.12% 182
2023
Q2
$715K Buy
3,203
+343
+12% +$70.1K 0.09% 213
2023
Q1
$632K Buy
+2,860
New +$705K 0.11% 184
2022
Q3
Sell
-991
Closed -$207K 315
2022
Q2
$207K Sell
991
-209
-17% -$46.6K 0.05% 300
2022
Q1
$265K Buy
+1,200
New +$253K 0.05% 276
2020
Q3
Sell
-550
Closed -$42K 236
2020
Q2
$42K Buy
550
+140
+34% +$9.51K 0.02% 407
2020
Q1
$23K Hold
410
0.02% 455
2019
Q4
$30K Buy
+410
New +$27.4K 0.02% 423

Other funds holding ALB

Procyon Advisors's ALB Position: Q2 2024 in Review

Procyon Advisors sold out of Albemarle (ALB) in Q2 2024, closing a stake of 4,229 shares — an estimated $557K sold.

Procyon Advisors first reported a position in ALB in Q4 2019 and held it in 10 quarters. The position peaked at $1.12M in Q3 2023. 843 funds tracked by Wall St. Rank hold ALB as of Q2 2024.

  • Procyon Advisors reported no remaining Albemarle position as of Q2 2024 after selling out during the quarter.
  • Procyon Advisors sold 4,229 Albemarle shares in Q2 2024, an estimated $557K.
  • Procyon Advisors first reported a position in Albemarle in Q4 2019 and held it in 10 quarters.
  • Procyon Advisors's Albemarle position peaked at $1.12M in Q3 2023.
  • 843 funds tracked by Wall St. Rank held Albemarle as of Q2 2024.

Based on Procyon Advisors's 13F filing for Q2 2024, filed 2 Aug 2024.